Newsroom « Galleon Pharmaceuticals

Newsroom

11-Apr-2013	Galleon Pharmaceuticals Demonstrates Successful Clinical Proof-of-Concept for Lead Product from Sleep Apnea Drug-Discovery Platform
20-Sep-2012	Galleon Pharmaceuticals Reports Positive Results from Second Phase I Study of GAL-021 for Treatment of Respiratory Depression
7-May-2012	Galleon Pharmaceuticals Reports Positive Results from Phase I Study of GAL-021 For Treatment of Respiratory Depression
1-Dec-2011	Galleon Pharmaceuticals Names Lynne Brookes Senior Vice President and Chief Business Officer
1-Nov-2011	Galleon Pharmaceuticals Names Two Executives to Senior Drug Discovery and Clinical Development Positions
26-Oct-2011	Thomas Dietz, Ph.D, Elected Chairman of Galleon Pharmaceuticals
1-May-2006	Galleon Pharmaceuticals is named SR ONE Biotech Company of the Year for Innovative Approach in Developing Sleep Apnea Medicines